Exagen Inc.
Price Action
Technical Summary
CONSOLIDATINGExagen Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 74), indicating performance broadly in line with the market. Earnings growth of 15% provides fundamental context to the price action. However, price is extended 22% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.54 | +4.61% | ABOVE |
| 50 SMA | $3.91 | +21.60% | ABOVE |
| 100 SMA | $3.55 | +33.62% | ABOVE |
| 150 SMA | $4.40 | +8.04% | ABOVE |
| 200 SMA | $5.94 | -20.00% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is XGN in an uptrend right now?
XGN has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is XGN overbought or oversold?
XGN's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.
Is XGN outperforming the market?
XGN has a Relative Strength (RS) Rating of 74 out of 99. XGN is performing about average compared to the market.
Where is XGN in its 52-week range?
XGN is trading at $4.75, which is 39% of its 52-week high ($12.23) and 22% above its 52-week low ($2.61).
How volatile is XGN?
XGN has a Beta of 1.89 and 52-week volatility of 70%. It's more volatile than the S&P 500 - expect bigger swings.